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Abstract
The choroid plexus (CP) are highly vascularized branched structures that protrude into the ventricles of the brain, and form
a unique interface between the blood and the cerebrospinal fluid (CSF), the blood-CSF barrier, that are the main site of
production and secretion of CSF. Sex hormones are widely recognized as neuroprotective agents against several
neurodegenerative diseases, and the presence of sex hormones cognate receptors suggest that it may be a target for these
hormones. In an effort to provide further insight into the neuroprotective mechanisms triggered by sex hormones we
analyzed gene expression differences in the CP of female and male rats subjected to gonadectomy, using microarray
technology. In gonadectomized female and male animals, 3045 genes were differentially expressed by 1.5-fold change,
compared to sham controls. Analysis of the CP transcriptome showed that the top-five pathways significantly regulated by
the sex hormone background are olfactory transduction, taste transduction, metabolism, steroid hormone biosynthesis and
circadian rhythm pathways. These results represent the first overview of global expression changes in CP of female and male
rats induced by gonadectomy and suggest that sex hormones are implicated in pathways with central roles in CP functions
and CSF homeostasis.
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Introduction
The choroid plexus (CP), located in the cerebral ventricles, are
branched and highly vascularized structures consisting of numer-
ous villi, in which blood microvessels are enclosed by a single layer
of cubical epithelial cells [1]. As a multipurpose organ, many
functions have been attributed to CP, which depend primarily on
the epithelial cells of this tissue. The best known function of CP is
cerebrospinal fluid (CSF) formation, which not only regulates
homeostasis in the central nervous system (CNS), providing
buoyancy for the brain and spinal cord, but also participates in
neural stem cell renewal, neuroprotection, sleep/awake cycles and
in several neurological disorders [2]. CP is also known to
participate in other functions that could be relevant in neurode-
generative diseases, as the control of the nutrient and hormone
supply to the brain and CSF, the clearance of deleterious
compounds and metabolites from the brain and the repair
processes following brain damage [1,3]. Moreover, the CP also
participates in brain detoxification processes, neurohumoral brain
modulation and neuroimmune interactions [3]. As a secretory
engine, CP synthesizes biologically active substances, and recent
studies demonstrated that these secretion might be delivered to the
brain by encapsulated CP transplants, and minimize or prevent
neural degeneration, particularly in models of stroke and
Huntington’s disease [4]. Moreover, the CP is also a target of
centrally released transmitters [5]. In line with this multiplicity of
functions, CP expresses a broad array of receptors and peptides;
cytokines and cytokine receptors involved in the inflammatory
processes, [6]; several receptors for neurotransmitters, growth
factors and neuroprotective peptides [7]; sex hormone receptors,
such as progesterone [8], estrogen receptors alpha and beta [9]
and androgen receptors [10] suggesting that CP is also a target
tissue for sex hormones. All the properties described above allow
the CP to monitor the contents of the CNS extracellular fluid and
respond to changes, for instance hormone alterations [11].
Recent studies provide insight into the neuroprotective effects of
sex hormones and on their beneficial effects in neurodegenerative
diseases [12,13], particularly in Alzheimer’s disease (AD),
a pathology often associated with sexual hormone levels decline.
In AD, CP synthesis, secretory, and transportation functions are
significantly altered resulting in decreased CSF turnover [14]. The
expression of some proteins including transthyretin [15], apolipo-
protein J [16], gelsolin [17] and insulin growth factor 2 are also
significantly decreased. In addition, some of these CP expressed
proteins, such as beta-APP, glial cell line-derived neurotrophic
factor, apolipoprotein E, brain derived neurotrophic factor [7] and
transthyretin [18,19], also implicated in neuroprotection and
neurodegeneration, are estrogen and/or androgen responsive.
PLOS ONE | www.plosone.org 1 April 2013 | Volume 8 | Issue 4 | e60199
Although many mRNA/proteins are differentially expressed in the
CP in response to sex hormones, many others with distinct
functions may be as well regulated by sex steroid hormones (SSHs)
in CP with unknown consequences. Moreover, it is expected that
increased knowledge about the physiology of CP will enable better
understanding or even treating some brain diseases [20]. To gain
additional insight into the functional role of SSHs in CP, the
present study compared gene expression patterns between sham
and gonadectomized (GDX) female/male rats CP and bring about
new mechanisms and pathways potentially regulated by SSHs.
Materials and Methods
Ethics Statement
Animals were handled in compliance with the NIH guidelines
and the European Union rules for the care and handling of
laboratory animals (Directive 2010/63/EU). Animal experiments
were also carried out according to the Portuguese law for animal
welfare and the protocol was approved by the Committee on the
Ethics of animal Experiments of the Health Science Research
Centre of the University of Beira Interior (DGV/2011). Moreover,
all efforts were made to minimize animal suffering.
Animals and tissue collection
Wistar rats were housed under a 12-h light, 12-h dark cycle,
with food and water ad libitum during the course of the experiment.
Female and male rats (2 months62 weeks) were either ovariecto-
mized (OVX) or orchidectomized (OOX). Two weeks after
surgery, castrated animals were anesthetized with a mixture of
ketamine and medetomidine. Blood was collected to confirm
hormone decline. Cerebral hemispheres were separated and both
lateral ventricular CP removed and immediately frozen in liquid
nitrogen. All samples were processed simultaneously to maximize
the reproducibility of the results.
Measurement of hormone levels
A blood sample was collected from the right atrium of the heart.
Estradiol (E2) and testosterone (T) levels in plasma were measured
by radioimmunoassays (RIAs) following the methodology de-
scribed in [21]. Intra-assay and inter-assay precision (coefficient of
variation) were 7.5% and 12.4% for T, and 6.9% and 8.3% for
E2, respectively. The limit of detection of assays was 50 pg ml21
for E2 and 200pg ml21 for T. Statistical analysis was performed by
Student’s t-test and p-values were considered statistically signifi-
cant at p,0.05.
Microarray experimental design
For microarray analysis pools of 2 CP from each animal (each
containing tissue removed from the lateral ventricles) were
prepared. Total RNA was extracted using TRIzol reagent
(Invitrogen, Carlsbad, CA, USA) following manufacturer’s in-
structions. RNA was quantified using a NanoDrop spectropho-
tometer (NanoDrop Technologies), and RNA integrity was
assessed by Bioanalyzer 2100 (Agilent Technologies, Santa Clara,
CA, USA). All RNA samples used in this study had an A260/A280
ratio of.1.9. Pools of RNA samples from three animals were
biological replicates. Equal amounts of RNA extract (200ng) from
the 3 pools of sham or 3 pools of GDX animals, in a total of three
biological replicates, were amplified and Cy-3-labeled using the
Low Input Quick Amp Labeling kit (Agilent Technologies).
Hybridizations were carried out on an Agilent-based microarray
platform using custom-designed whole genome Rat GE 4x4K v3
microarrays, and arrays were scanned with an Agilent microarray
scanner (Agilent Technologies). Scanned images were analyzed by
Feature extraction software (Agilent Technologies) using
GE1_105_Dec08 protocol. The signal intensity was normalized
between microarrays by centering the median of the signal
distribution using BRB-ArrayTools v3.8.1 (http://linus.nci.nih.
gov/BRB-ArrayTools.html).
Microarray data analysis
Differentially expressed genes were identified by pairwise
comparison using a Student’s t-test, with a p-value cut-off of
0.05. Only genes with a fold change above 1.5 were considered
differentially expressed for further analyzes.
In order to identify pathways with a significant number of
differentially expressed genes, the lists of differentially expressed
genes from the female and male groups were imported into the
database for Annotation, Visualization and Integrated Discovery
(DAVID) v6.7 http://david.abcc.ncifcrf.gov/ [22]. Significantly
enriched KEGG (Kyoto Encyclopedia of Genes and Genome
http://www.genome.jp/kegg/pathway.html) pathways and Gene
Ontology (GO) terms for Biological Process, Molecular Function
and Cellular Component were identified using a p-value cut-off of
0.05. Redundant terms and categories comprising less than five
genes were omitted.
Real-Time qPCR validation
Quantitative Real-Time PCR was used to validate the
microarray data for 15 selected target genes. Total RNA was
prepared from lateral ventricular CP from the same pool of
animals as outlined above. First-strand cDNA was synthesized
using M-MLV Reverse Transcriptase (Invitrogen). Real-time
qPCR was performed using SYBR Green assay and the
iCycleriQTM system (Bio-Rad). Cycling parameters for all
reactions were as follows: denaturation at 95uC for 10 min; 40
cycles of denaturation at 95uC for 15 sec and 1 min of annealing
and extension at 60uC. Gene expression was determined relative
to levels of expression of Cyclophilin A using the comparative Ct
(22DDCt) method, with Ct denoting threshold cycle. Gene
expression of Cyclophilin A has been shown not to change
between sham and GDX animals. Standard deviations were
calculated from triplicates of three separate samples from each
group. For each sample, average Ct for each target gene was
calculated as the mean of 3 technical replicates; DCt was
calculated as the difference in average Ct of the target gene and
the endogenous control gene. For each group, mean 22DCt was
calculated as the geometric mean of 22DCt of the 3 samples of the
group. Fold change was then calculated as mean 22DCt (GDX
group)/mean 22DCt (sham group). Fold change values above 1.0
indicate a positive expression or up-regulation relative to sham
group. Fold change values below 1 indicate a negative expression
or down-regulation relative to the sham group. Primers for target
genes were designed using Primer-Blast-NCBI-NIH and are listed
in Table 1. In addition, the resulting PCR products were run on
a 1.5% agarose gel and bands were sequenced to verify the
sequence identity.
Results
Characterization of the hormonal status of the animals
The efficacy of gonadectomy was confirmed by comparing
serum E2 and T levels. In addition body weight gain and uterus
weight of sham females were compared with OVX animals
(Table 2). Serum E2 levels in ovariectomized (0.03660.0036ng/
mL) were significantly lower than in control animals
(0.05260.0034 ng/mL). Differences between OVX and sham
animals in body weight gain (34.2462.286 vs. 11.0962.211 g/
Sex Hormone Responsive Genes in Rat Choroid Plexus
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animal) and uterus weight (0.05160.003 vs. 0.11860.008 mg)
reached statistical significance in both cases. In rat males, serum T
levels decreased from an average of 2.62560.445 ng/mL in sham
animals to 0.23860.0534ng/mL after surgery. No differences
were found in body weight between OOX (38.0263.736 g/
animal) and sham animals (31.97610.03 g/animal).
Genes differentially expressed in CP in response to
gonadectomy
Microarray analysis of whole CP genome expression in OVX
compared to sham female rats identified more than 6,000 (p-
value,0.05) differentially expressed genes (approximately 25%).
Differences in the transcriptome of OOX males compared with
sham ranged approximately 15% of the rat CP transcriptome.
Using a 1.5– fold change as a cut-off, 1168 genes (4.7%) were up-
regulated in CP of female OVX rats, while in CP male rats only
426 genes (1.7%) were up-regulated (Table 3) relative to sham
animals. The same trend can be seen in Table 3, for down-
Table 1. Primers used to validate microarray results by Real-Time PCR.
Gene name Gene symbol ID Primer forward and reverse Product size
Bcl2-like1 Bcl2l1 NM_001033670 TTCGGCACGAGCAGTCAGCC ACCAGCTCCCGGTTGCTCTGA 160bp
Mdm4 p53 binding protein homolog
(mouse)
Mdm4 NM_001012026 CACGGTGCAACAGAGTGCTCC ACCAAGGCAGGCCAGCAACA 190bp
Insulin degrading
enzyme
Ide NM_013159 TGGCTGTGGACGCACCAAGGA GGGTGGCGCTTCGGAAAGGT 125bp
Nibrin Nbn NM_138873 AGTCATCCCCAGTGCGCCAA TCGGGGCCTTTCCCCTAACCA 233bp
Cullin 2 Cul2 NM_001108417 TGCTTCGGCACAACGCCCTC TGCTTGGCTGCGCTCGATGT 131bp
Spermidine synthase Srm NM_053464 GCGCTCGCGGTACCAAGACA TCAGCACCTTCCGCGGGTTG 164bp
Presenilin 1 PSen1 NM_019163.3 GAGGAAGACGAAGAGCTGACA
GAAGCTGACTGACTTGATGGTG
114bp
Cystatin C Cst3 NM_012837.1 TGGTGAGAGCTCGTAAGCAG GCTGGATTTTGTCAGGGTGT 203bp
Cathepsin D Ctsd NM_134334.2 GGCATGGGCTACCCTTTTAT GACAGCTCCCCGTGGTAGTA 182bp
Transferrin Tf NM_001013110.1 GCATCAGACTCCAGCATCAA CAGGACAGTCTGGTGCTTCA 312bp
Insulin-like growth
factor 2
Igf2 NM_001190162.1 TGTCTACCTCTCAGGCCGTACTT GTGGCGCTTGGCCTCTCTGA 185bp
Cyclophilin A Ppia NM_017101.1 CAAGACTGAGTGGCTGGATGG
GCCCGCAAGTCAAAGAAATTAGAG
163bp
Transthyretin TTR NM_012681.2 GGACTGATATTTGCGTCTGAAGC
ACTTTCACGGCCACATCGAC
119bp
Beta-2 microglobulin B2m NM_012512.2 CCGTGATCTTTCTGGTGCTTGTC
CTATCTGAGGTGGGTGGAACTGAG
150bp
doi:10.1371/journal.pone.0060199.t001
Table 2. Serum E2 and T levels, and body and uterus weight in rats at the time of sacrifice.
Female Sham rats
Female ovariectomized
rats Male Sham rats Male orchidectomized rats
No. of animals (n) 8 8 8 8
Change in serum E2 level (ng/mL) 0.05260.0034 0.03660.0036 ** - -
Change in serum T level (ng/mL) - - 2.62560.445 0.23860.0534***
Change in body weight (g) 11.0962.211 34.2462.286*** 31.97610.03 38.0263.736
Uterus weight (mg) 0.118460.008 0.05160.003*** - -
Values are means6SEM. Differences between gonadectomized and sham-operated rats were assessed using Mann-Whitney test: **p,0.001; ***p,0.0001.
doi:10.1371/journal.pone.0060199.t002
Table 3. Number of up and down-regulated genes in rat CP
in response to ovariectomy or orchidectomy.
Fold-change
Females
No. of genes (% of
genome)
Males
No. of genes (% of
genome)
Up-regulated
.1.5 1168 (4.7%) 426 (1.7%)
.2.0 422 (1.7%) 156 (0.62%)
.5.0 11 (0.04%) 20 (0.08%)
Down- regulated
.1.5 1328 (5.3%) 123 (0.5%)
.2.0 141 (0.56%) 36 (0.14%)
.5.0 29 (0.12%) 3 (0.012%)
doi:10.1371/journal.pone.0060199.t003
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regulated genes, with 1328 genes (5.3%) being down-regulated in
CP of female rats and 123 genes (0.5%) in CP of male rats.
To further understand the biological relevance of these gene
expression profiles, we carried out bioinformatic analyses to
determine the pathways and GO terms most significantly
associated with these genes.
Functional annotation analysis
In order to explore altered functional pathways in response to
gonadectomy in female and male rat CP, we used the
bioinformatics database DAVID. Pathway enrichment analysis
was performed by comparing each list of differential expressed
genes to all available biological pathways provided by KEGG. The
subsequent KEGG-test analysis revealed 11 KEGG-pathways that
were significantly changed (Table 4). The most affected pathway
was olfactory transduction (102 up-regulated and 282 down-
regulated genes in female rat CP and 42 up-regulated genes in
male rats CP; Tables S1 and S2). Statistically significant changes
were also found for genes involved in primary immunodeficiency,
steroid hormone biosynthesis, taste transduction, maturity onset
diabetes of the young, retinol metabolism, drug metabolism,
metabolism of xenobiotics by cytochrome P450, pentose and
glucuronate interconversions, ascorbate and aldarate metabolism
and circadian rhythm (Table 4). Two of the pathways mentioned
above, namely olfactory transduction and steroid hormone
biosynthesis, were similarly regulated in female CP and in male
rat CP. However, several pathways were exclusively up-regulated
in female CP (Tables S1 and S7), such as primary immunodefi-
ciency (7 genes; p=8.5E-3), taste transduction (7 genes; p=4.6E-2)
and maturity onset diabetes of the young (6 genes; p=1.1E-2). On
the other hand, genes involved in retinol metabolism (18 genes;
p=6.4E-6), drug metabolism (16 genes; p=1.1E-3), metabolism of
xenobiotics by cytochrome P450 (15 genes; p=4.9E-4), pentose
and glucuronate interconversions (6 genes; p=7.1E-3) and
ascorbate and aldarate metabolism (6 genes; p=1.3E-2), were
significantly down-regulated only in female rat CP (Tables S1 and
S7).
Computational analysis allowed the detection of significantly
enriched GO terms associated according to Biological Process,
Molecular Function and Cellular Component.
Using DAVID analysis, the Biological Process domain of the
Gene Ontology database provided the most extensive pathway
assignments. Consistent with the pathway profiles, CP down-
regulated male genes, were linked to biological processes (Fig. 1A)
related to RNA metabolism (30 genes) and circadian rhythm
process (6 genes) (Table S3). The majority of up- and down-
regulated CP female genes and up-regulated CP male genes were
related to signal transduction and response to stimulus (Fig. 1A).
Interestingly, there was a massive up- and down-regulation of CP
female genes related to the subcategories of cell surface receptor
linked signal transduction and G-protein coupled receptor protein
signaling pathways (Tables S4 and S5). The same was observed for
genes up-regulated in CP of males (Tables S6 and S8). As shown
in Tables S4, S5 and S6, the majority of differentially expressed
genes corresponded to genes involved in the neurological system
processes, cognition and sensory perception. In terms of response
to stimulus, the most prominent processes affected were related to
detection of chemical stimulus involved in sensory perception
(Tables S4, S5 and S6). Regarding genes up-regulated in female
rat CP, there was a significant overrepresentation in the
subcategories of immune response (38 genes; p=2.3E-3), defense
response (36 genes; p=4.1E-3) and acute inflammatory response
(12 genes; p=1.0E-2) (Table S4). Down-regulated genes in female
rat CP were exclusively included in the categories of hormone
metabolic process (17 genes; p=5.7E-3) and retinoic acid
metabolic process (7 genes; p=6.4E-4), among others (Table S5).
Male rat up-regulated genes related to reproduction were also
significantly overrepresented (Table S6), indicating that a larger
number of genes in this category increased in OOX animals.
Under the Molecular Function category (Fig. 1B) olfactory
receptor activity, hormone activity, peptide regulator activity,
hydroxylase activity and catalytic activity were overrepresented
among the up- and down-regulated genes in female rat CP.
Extracellular matrix structural constituents, sequence-specific
Table 4. KEGG pathways with significant association with genes differentially expressed in female and male rat choroid plexus.
Females Males
Up-regulated Down-regulated Up-regulated Down-regulated
Kegg pathways
Number of
genes P-value
Number of
genes P-value
Number of
genes P-value
Number of
genes P-value
Olfactory transduction 102 3.1E-12 282 1.7E-99 42 5.1E-5
Primary immunodeficiency 7 8.5E-3
Steroid hormone biosynthesis 7 2.6E-2 15 8.8E-6 5 1.7E-2
Taste transduction 7 4.6E-2
Maturity onset diabetes of the
young
6 1.1E-2
Retinol metabolism 18 6.4E-6
Drug metabolism 16 1.1E-3
Metabolism of xenobiotics by
cytochrome P450
15 4.9E-4
Pentose and glucuronate
interconversions
6 7.1E-3
Ascorbate and aldarate
metabolism
6 1.3E-2
Circadian rhythm 3 3.0E-3
doi:10.1371/journal.pone.0060199.t004
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DNA binding and carbohydrate binding proteins were exclusively
up-regulated, whereas pheromone receptors, channels, cytokines
and binding proteins were exclusively down-regulated in female
rat CP. Olfactory receptors, channels, neurotransmitter receptors,
signaling receptors and transmembrane transporters were over-
represented among the up-regulated genes in male rat CP,
whereas regulation of RNA metabolism followed the opposite
tendency.
Finally, under the Cellular Component category (Fig. 1C),
integral to membrane and extracellular region were overrepre-
sented among the up- and down-regulated genes in female rat CP
and up-regulated genes in male rat CP. Acrossomal vesicle and
axoneme were exclusively up-regulated in female rat CP. In
addition, nucleossome, keratin filament and ion channel complex
were exclusively up-regulated in male rat CP, whereas basolateral
plasma membrane followed the opposite tendency.
Validation of microarray results by quantitative Real-Time
PCR analysis
To validate gene expression changes in rat CP induced by
gonadectomy in the microarray analysis, qRT-PCR was per-
formed in 15 genes that were either up or down-regulated in
female or male GDX compared to sham animals. For 13 of these
15 genes there was complete agreement between the microarray
results and the qRT-PCR results (Table 5). For almost all the cases
the fold changes measured by qRT-PCR were less than those
recorded using the microarray assay. For the two genes that were
not consistent between the two methodologies, the microarray
method gave an up-regulation of transcription, whereas the qRT-
PCR method showed a down-regulation in the transcriptional
response.
Discussion
CP is a brain structure involved in a variety of neurological
disorders, including neurodegenerative, inflammatory, infectious,
traumatic, neoplastic, and systemic diseases [20]. Moreover, the
CP actively secretes CSF into the brain ventricles and creates the
blood-CSF barrier. For this reason, CP epithelial cells may
respond to factors released into the CSF following brain damage
[2]. The CP has also been implicated in neuroendocrine signaling
[23], amyloid clearance [24] and thyroid hormone distribution
[25]. It has been demonstrated that CP also express sex hormone
receptors, and synthesizes some peptides implicated in neuropro-
tection and neurodegeneration which are hormone responsive
[26,27]. Although there is evidence that the regulation of some of
the molecules synthesized in CP, such as transthyretin, gelsolin
and vasopressin [20] may have implications in the treatment of
brain diseases, an analysis of the effects of SSHs on the
transcriptome of female and male rat CP had never been done
before.
To our knowledge, this study shows for the first time the
response of the transcriptome of female and male rat CP to
a decline in sex hormone levels induced by gonadectomy. The
results presented here were validated by qRT-PCR, which
confirmed the differential expression of selected candidate genes.
Compared to sham animals, gonadectomy generated more
transcriptional changes in females than in males. As mentioned
earlier in the results section, 2496 genes were differentially
expressed more than 1.5-fold in CP from OVX compared to
sham female rats.
KEGG functional pathway analysis in females revealed the
enrichment of a variety of processes of CP physiology represented
mostly by chemical senses pathways, such as the olfactory system
Figure 1. Gene ontology (GO) term enrichment analysis of differentially expressed genes. Biological processes (A), Molecular functions
(B) and Cellular components (C).
doi:10.1371/journal.pone.0060199.g001
Table 5. Comparison of microarray and Real-Time PCR fold-changes of 15 selected genes differentially expressed in choroid plexus
of gonadectomized female and male rats.
Gene Gene name Microarray Real-Time PCR
FEMALES
Bcl2l1 Bcl2-like 1 1.61 0.59
Mdm4 Mdm4 p53 binding protein homolog (mouse) 1.39 0.96
Srm Spermidine synthase 1.19 0.57
Ide Insulin degrading enzyme 0.94 0.68
Nbn Nibrin 0.81 0.48
Cul2 Cullin 2 0.83 0.62
MALES
Ide Insulin degrading enzyme 1.10 1.33
Psen1 Presenilin 1 0.80 0.59
Bcl2l1 Bcl2-like 1 0.66 0.64
Cst3 Cystatin C 0.82 0.63
TTR Transthyretin 0.81 0.95
Ctsd Cathepsin D 0.79 0.94
Tf Transferrin 0.81 0.76
Igf2 Insulin-like growth factor 2 0.81 0.93
B2m Beta-2 microglobulin 0.86 0.74
doi:10.1371/journal.pone.0060199.t005
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and taste transduction and metabolic pathways, such as retinoic
acid and xenobiotic detoxification pathways. It was recently
reported that taste receptor genes Tas1r1, Tas1r2, Tas1r3, and
their associated G-protein genes were detected in the intra-
ventricular epithelial cells of CP, probably allowing neurons to
have proximal access to the contents of the CSF and to modulate
their responses [28]. Previous evidence on the regulation of this
pathway by the hormonal background showed that female rats
experience changes in taste bud morphology during pregnancy
[29]. Moreover the response of the parabrachial pons to bitter
taste is increased in OVX rats comparing to controls [30]. Hence,
it seems likely that sex hormones affect taste and nutrient sensing
both at the level of the taste buds as well as in the CNS [31]. In our
study, declination of hormone levels clearly induced an up-
regulation of 7 genes, including taste receptor genes and
phospholipase C beta2, which were associated with taste trans-
duction. Interestingly, in our study we identified differentially
expressed receptors of the Tas2r family, important for the
detection of bitter-tasting compounds [32]. Our comparative gene
expression analysis provides the first evidence that the expression
of taste-related genes in rat CP are under the control of SSHs.
Finally, the fact that changes in expression levels occurred in CP
suggests a role for this tissue as a taste sensor in the brain, most
likely specialized in ‘‘tasting’’ the chemical composition of the
CSF.
Hormone decline in rat CP had also important effects on other
chemical sensing pathways, namely olfactory transduction signal-
ing, with 102 genes being up-regulated and 282 genes being down-
regulated. Among these differential expressed genes, most are
olfactory receptors (ORs).There is evidence that SSHs trigger
alterations in olfactory function in humans [33], and steroid
hormones such as androstenone and androstadienone were
identified as ORs ligands [34]. Initially identified in the sensory
neurons of the olfactory epithelium, recent studies showed that
different tissues throughout the body also expressed ORs [35], in
different cell types, such as sperm, testis and kidney [36]. In these
tissues their potential functions are unknown, but putative sensory
roles have been proposed. Other interesting gene differentially
expressed in rat female CP was phosducin. Phosducin is a protein
highly abundant in the retinal photoreceptor cells and pine-
alocytes. However, higher levels of phosducin were also found in
a small number of brain cells, such as habenular commissura,
superior colliculus, ventral tegmental area and amygdala [37].
Together, our current transcriptome results suggest a possible
function of CP in olfactory transduction, where OR genes may not
function as odorant receptors but have other functions with
important implications in the surveillance of the CSF composition.
In fact, the expression of the olfactory signaling system has been
previously found in the kidney and placenta [36,38]. To our
knowledge, this is the first report indicating the presence of the
olfactory transduction machinery in CP, a barrier organ like the
kidney and placenta.
Five metabolic pathways among the eleven pathways signifi-
cantly modulated by hormone decline were: retinol metabolism,
drug metabolism, metabolism of xenobiotics by cytochrome P450,
pentose and glucuronate interconversions and ascorbate and
aldarate metabolism. The overrepresentation of 18 significantly
down-regulated genes in female CP transcriptome that were
related to retinol metabolism, are in accordance with previous
results described in other tissues [39,40]. The components
involved in retinoic acid homeostasis and in the metabolism and
function of retinoids have been localized in cell populations of
vascular and nervous tissues of the adult rat CNS [41], particularly
in CP [42,43]. Romand et al. revealed that retinol dehydrogenase
(RDH10), shown to represent a limiting factor in the synthesis of
retinoic acid, is present in the CP [44]. The down-regulation of
RDH10 in female rat CP was demonstrated in our study,
suggesting a possible role of SSHs in the production of
retinaldehyde from retinol in CP that could be essential for the
CNS development [44]. Moreover, several studies also suggest
that, there will be different factors that regulate retinoic acid
synthesis. Estrogens, for instance, coordinately up-regulate retinoic
acid production and signaling in the human endometrium [39].
Furthermore, induction of the biosynthesis of retinoic acid occurs
in the uterus of OVX rat, after estradiol administration [40].
Taken together, our current results together with the studies
described above strongly favor the idea that SSHs, particularly
estrogens, regulate CP retinol signaling.
We also confirmed the down-regulation of genes encoding
molecules involved in the metabolism of drugs and xenobiotics.
Long recognized for its great ability as a reabsorbing organ, the
CP was once regarded as being primarily a tissue for clearing
noxious substances [45], since the reabsorption of brain catabolites
and drug metabolites by epithelial cells pivotally maintains CSF
purity [46]. Alcohol dehydrogenase and cytochromes P450 are of
particular interest in the metabolism of ethanol in the brain. In our
study, we showed a down-regulation of alcohol dehydrogenase
class IV (ADH4) and cytochromes P450 2 and 3 in female rat CP.
Our results are in concordance with the study of Martinez et al.,
who identified the presence of ADH1 and ADH4 in rat CP,
suggesting a function of these enzymes as metabolic barriers [47].
Moreover, the rat CP has also been shown to be immunoreactive
for Cyp1A1, an isoform involved in the metabolism of carcino-
genic polycyclic aromatic hydrocarbons [48]. This isoform was
identified in our microarrays results and is also down-regulated in
female rat CP. It is interesting to note that steroid hormones
contribute to the transcriptional regulation of enzymes that are
involved in the metabolism of drugs and xenobiotics, such as
P450s [49]. These observations are in agreement with our
findings, suggesting that SSHs could exert a protective mechanism
in CP, through the regulation of molecules involved in drug
metabolism.
The identification of down-regulation of cytokine activity is
consistent with the presence of cytokine receptors in CP epithelial
cells [5]. In fact, CP secretes several inflammatory mediators that
may change in response to specific stimuli [50]. Microarray
analysis of the mouse CP gene regulation after inflammatory
stimuli showed that the expression of several chemokines was
altered [50]. Biological function annotation and enrichment
showed the up and down-regulation of genes involved in a variety
of processes, affecting several fields of the cell physiology, as signal
transduction and response to stimulus. Other two well-represented
subcategories such as immune system process and response to
stress contain up-regulated genes whose functions may influence
the interaction of molecules of the immune system with stress
response. This hypothesis, if true, is in agreement with recent
microarray observation indicating that chronic stress altered the
rat CP expression of several genes, up-regulating genes involved in
immune responses, such as, IL1b and TNF-a [51].
Enrichment analysis for cellular component and molecular
function showed that the main enriched significantly up- and
down-regulated genes found in these categories code for integral
membrane proteins and also proteins found in the extracellular
region with binding and catalytic activity. This finding corrobo-
rates the existence of a complex regulation of intracellular
networks that control the catabolic processes triggered by SSHs
upon reception of external stimulus from the peripheral circulation
and/or the CSF.
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Comparing CP gene expression from OOX with sham rat male,
we have identified 549 genes differentially expressed 1.5-fold or
above. When the up- and down-regulated genes were input into de
KEGG pathway database, some clustering of transcriptional
responses was evident, showing that orchidectomy induced
differential expression of genes associated with steroid hormone
biosynthesis and circadian rhythm.
In CP of rat males, orchidectomy clearly induced an up-
regulation of steroid hormone biosynthesis, with five genes being
up-regulated, such as Cytochrome P450 isoforms and 17-beta
dehydrogenase 3. We have identified here, the presence of
Cyp11b2, Cyp11b3 and of Cyp11b1 in rat CP. The later has been
confirmed earlier by other authors [52]. These results suggest that
circulating hormones could regulate the synthesis of mineralocor-
ticoids and glucocorticoids in the CP and probably modulate CSF
volume and electrolyte concentrations [52]. In the brain, emerging
evidence indicates that, steroids directly synthesized within the
CNS, either de novo from cholesterol or by in situ metabolism of
circulating steroid precursors play an important role as endoge-
nous modulators of neuronal functions and behavioral processes,
and that alterations of neurosteroid concentrations may contribute
to the pathophysiology of neuronal disorders [53]. Altogether,
these findings suggest that CP may be a new steroidogenic organ
responding to alterations in the blood and CSF hormonal
composition through the activation of its own steroidogenic
machinery.
Other interesting results were the decreased expression of three
genes (basic helix-loop-helix family, period homolog 2 and 3),
which integrate the mammalian circadian clock and play an
important role in maintaining or organizing circadian rhythm
[54]. The results obtained in our study are in agreement with the
description of a relationship between androgens and circadian
timing system, in which androgens modulate the hypothalamic
suprachiasmatic nucleus timekeeping in a dose-dependent manner
[55]. Moreover, at the behavioral level, gonadectomy produces
a dramatic loss of the evening activity in male mice, that could be
restored by testosterone treatment, suggesting that androgenic
hormones regulate circadian responses [56].
The up-regulated rat male CP transcriptome was enriched with
genes that clustered in ontologies characteristic of transport
activity and binding, which are in accordance with the
subcategories of integral to membrane and ion channel complexes.
Specifically, the enrichment of genes in Biological process: signal
transduction and response to stimulus is indicative of the
importance of SSHs in the perception of molecular signals and
the regulation of cellular downstream processes in CP. Down-
regulated rat male genes in CP transcriptome enriched cellular
component for basolateral plasma membrane. Enriched molecular
functions indicated that down-regulated genes encoded proteins
that regulate channel and cytokine activity and RNA metabolic
processes.
Conclusions
This is, to our knowledge, the first study demonstrating
transcriptional regulation of female and male rat CP genes in
response to different hormonal backgrounds. The GDX female
and male CP suffered changes in the expression of genes
associated with several pathways. Although more pronounced in
females than in males, most of these CP expression changes
occurred in genes implicated in chemical sensing, metabolism,
steroid hormone biosynthesis and circadian rhythm pathways,
adding to CP other putative functions that account for the efficient
regulation of the CNS homeostasis and CSF composition.
Moreover, the results described herein underscore the importance
of the SSHs in the regulation of target genes that may acquire
relevance as new potential therapeutic targets or agents to prevent
or delay neurological disorders, and their overall impact in CP
functions.
This work serves as a starting point for further studies, in order
to examine in detail the origin of the alterations observed and to
validate the observed changes using complementary approaches to
disclose the functional implications of our findings.
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